Gene Fusions Associated with Recurrent Amplicons Represent a Class of Passenger Aberrations in Breast Cancer
Open Access
- 1 August 2012
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 14 (8), 702-IN13
- https://doi.org/10.1593/neo.12914
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Transcriptional consequences of genomic structural aberrations in breast cancerGenome Research, 2011
- A census of amplified and overexpressed human cancer genesNature Reviews Cancer, 2010
- S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell ProliferationOnline Journal of Public Health Informatics, 2009
- CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcomeBreast Cancer Research and Treatment, 2007
- FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysisBreast Cancer Research, 2007
- AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinibBreast Cancer Research and Treatment, 2006
- EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutationsLaboratory Investigation, 2005
- C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevanceBritish Journal of Cancer, 2000
- Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.1999
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987